Can PVR be Prevented?

A surgeon suggests three levels of prophylaxis

Clinical Trial Update

Coding Q&A

Rules for scribing and extended ophthalmoscopy

Developing Effective Steroid/Anti-VEGF Combination Therapy Regimens

Recent additions to our therapeutic options have yielded new opportunities

Events Calendar

Focus On

The Merlin surgical viewing system

Innovation in Retina

Mark S. Blumenkranz: A Series of Successes

Intra-arterial Chemotherapy for Retinoblastoma

A promising treatment modality, with eyes and lives being saved

Journal Club

New and noteworthy studies

Macula 2011: Highlights From the Conference

Wills Eye's 50-year-old Retina Service hosts

Management and Intervention Strategies for Symptomatic Vitreomacular Adhesions

Wanted: options to replace "watchful waiting"

Ophthalmic OCT Reaches $1 Billion Per Year

But reimbursement clampdown clouds future innovation

Stem Cell Therapy in Retinal Diseases

Current preclinical research results and upcoming clinical trials

Subspecialty News

Selected highlights from ARVO presentations: Antibiotic after intravitreal injection? New concepts in sustained-release drugs; Predicting macular hole surgery; CATT study, and more

The Case for Navigated Retinal Laser Therapy

Navilas offers increased accuracy and reduced patient pain when treating DME

Tips on Improving Your Use of Endoillumination

Upfront: From the Editor-in-Chief

CATT out of the bag